The AGL Energy Limited (ASX: AGL) share price is continuing to fall, hitting a new 52-week low today.

The ASX-listed energy company’s shares have been on a multi-year decline. In 2017, the AGL share price hit an all-time high of $27.70 per share. Since then, shares have gradually eroded. At the time of writing, shares are down 2.36% on yesterday’s closing price to $7.87.

Consequently, one of Australia’s oldest companies is now trading at its lowest level since July 2004.

Investors seem to be growing unsure about AGL’s future with a proposed demerger a possible catalyst.

Uncertainty leaves the AGL share price bleeding

On 30 June 2021, AGL announced its intention to proceed with the proposed demerger. A swift 11% drop in the AGL share price followed. However, the company believes it would be in the best interests of shareholders.

The two separate entities will be known as Accel Energy Limited and AGL Australia Limited. One will focus on the accelerating energy transition, while the other will be a multi-product energy retailing business.

AGL Energy chairman Peter Botten said:

…the impact of recent challenging market conditions on our financial performance emphasises that AGL Energy is now at an inflection point, as the transition of the energy sector accelerates, driven by the rapid evolution in renewables and decentralised energy technology, customer needs and community expectations.

These impacts include falling wholesale electricity prices caused by an increased supply of solar and wind-generated electricity. Unsurprisingly, this has also weighed on the AGL share price.

Next steps

In the meantime, shareholders are waiting patiently to see whether the proposal receives regulatory approvals. According to the previous announcement, the demerger remains conditional on the final AGL board, Australian Tax Office, regulatory, court, and shareholder approval.

Additionally, shareholders are expected to vote via a scheme booklet in the fourth quarter of FY22. In any case, investors will be hoping the losses stem soon.

The AGL share price has collapsed 34% so far in 2021. Likewise, the market capitalisation of the company has tumbled to $4.92 billion.

The post AGL (ASX:AGL) share price checks in at new 52-week low appeared first on The Motley Fool Australia.

More reading

• The AGL share price is now trading on a 10% dividend yield
• Top brokers name 3 ASX shares to sell today
• Why the AGL Energy (ASX:AGL) share price has fallen 15% in 3 months
• It hasn’t been a great 2021 so far for the AGL (ASX:AGL) share price
• Top brokers name 3 ASX shares to sell today

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2UYMXVA

The S&P/ASX 200 Index (ASX: XJO) is down 0.2% in early afternoon trading, having recouped much of its earlier losses.

In morning trade, the ASX 200 slipped as much as 1.1%. Investors were hitting the sell button here in Australia following large selloffs yesterday (overnight Aussie time) across all the major US and European exchanges.

In the US, the S&P 500 (INDEXSP: .INX) fell 1.6%. The Dow Jones Industrial Average (INDEXDJX: .DJI) had an even worse day, tumbling 2.1%.

The usual bugbears appear to be behind much of the market losses. Namely lingering fears over inflation and rising interest rates, and renewed fears over the spread of the COVID-19 delta variant derailing the global economic recovery.

While those are both real risks to keep an eye on, below we look at why some market experts aren’t overly concerned.

Why these experts aren’t losing sleep over a market crash

The ASX 200 is down 0.9% over the past 5 days, and the S&P 500 is down 2.8% over that same time.

Does that mean the hard-charging bull run is over and we should brace for a share market correction of 10% or more? Or even a crash of 20% or more?

Not according to many market veterans.

Marko Kolanovic, chief global markets strategist at JPMorgan Chase, believes the latest round of selling is overdone. According to Kolanovic (quoted in the Australian Financial Review):

We expect the reflation trade – cyclical stocks, bond yields, high beta stocks, reflation and reopening themes – to bounce imminently as delta variant fears subside and inflation surprises persist.

Capital Economics’ Jonas Goltermann is also decidedly bullish, saying, “Despite some recent setbacks, we think the outlook is considerably brighter than it was then, which is why we still think that US bond yields will rebound.”

Chris Zaccarelli, chief investment officer for Independent Advisor Alliance, adds that while a retrace was expected, the mid-term outlook remains solid:

Valuations across the market as a whole had become stretched and we were due for a pullback. We remain optimistic that the economy is on strong footing and, although the path will be uneven, the trend is still toward increasing growth and higher corporate profits.

Buy the dip strategies on the ASX 200 and global markets

Most long-term investors will tell you it’s a fine line between buying the dip and catching a falling knife.

That means a lot of time when markets (or individual shares) are falling, they can keep falling even after you believe you’ve bought at the dip.

But 2021 has seen the strategy generally well rewarded. With the ASX 200 and S&P 500 rebounding after every selloff.

According to Randy Frederick, managing director of trading and derivatives for Charles Schwab Corp, (quoted by Bloomberg):

The dip buyers have stepped in very quickly and bought very quickly and that’s one of the reasons we haven’t had a full 10% correction – and frankly I don’t think we’ll have one this time either for that reason. Every dip has been bought and immediately paid off within a week or two of not just where it started but above.

Dan Egan, managing director of behavioural finance and investing at Betterment, agrees, saying, “There’s a lot of very young people in the accumulation phase. If they have any excess cash sitting around, they’re going to use it to buy in.”

Among the most bullish of the market experts is Michael Purves, founder and CEO of Tallbacken Capital Advisors. Yesterday, he raised his end of year target for the S&P 500 to 4,800 points. That’s 12.7% above today’s 4,258 points. Purves wrote:

We think the combination of low, and stable, interest rates with a strong earnings growth trajectory will support the equity risk premium at healthy levels at 4,800 at year end. While we are past peak earnings growth, the earnings growth story into and through 2022 will continue to be robust. Further, we find little evidence that a rollover in peak earnings growth is a reason to sell the market.

What about inflation fears?

If inflation rises faster than the central bank chiefs are forecasting, it could usher in higher interest rates sooner than expected. And that would put pressure on equity prices and send the ASX 200 lower.

However, Mark Hickson, 1851 Capital portfolio manager, doesn’t believe this poses significant near term risk, (quoted by the AFR):

The market is becoming more comfortable now with the outlook for inflation. We’re not too worried about inflation or rake hikes in the short term. The equity market typically peaks 12 months after the first rate hike, so we believe we still have a few years of good returns to come.

How the ASX 200 has moved

Despite a small fall over the past week, the ASX 200 remains up around 10% year-to-date. That’s a solid result by any measuring stick, though well behind the 15.1% gains posted by the S&P 500.

Over the past 12 months, the ASX 200 has gained 21.1%.

The post ASX 200 slips but these experts aren’t worried about a market crash appeared first on The Motley Fool Australia.

More reading

• Lockdowns hurt, ASX falls, Wesfarmers climbs, and the Aussie set to fall? Scott Phillips on Nine’s Late News
• This ASX fund manager is predicting big things for biotech shares
• Kogan (ASX:KGN) share price jumps 6% in a week
• 3 reasons why Pro Medicus (ASX:PME) is a top class share
• Why the Woodside Petroleum (ASX:WPL) share price is falling on Tuesday

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3BlPsSH

Motley Fool Australia Chief Investment Officer Scott Phillips joined Nine’s Late News on Monday night to discuss the cost of the ongoing lockdowns, the impact on the ASX, the resilience of the Wesfarmers share price and CBA’s forecast for a lower Aussie dollar.

The post Lockdowns hurt, ASX falls, Wesfarmers climbs, and the Aussie set to fall? Scott Phillips on Nine’s Late News appeared first on The Motley Fool Australia.

More reading

• ANZ’s (ASX:ANZ) $1.5bn buyback puts other ASX 200 banks under capital return spotlight
• Do ASX 200 banks share same BNPL ambitions as Westpac (ASX: WBC)?
• What happened on the US stock market overnight and how could it impact ASX shares?
• Is the Telstra (ASX:TLS) share price good value amid acquisition news?
• ASX 200 drops, Telstra falls, Altium declines

Motley Fool contributor Scott Phillips owns shares of Telstra Corporation Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Corporation Limited and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3hQlH4T

Platinum Asset Management Ltd (ASX: PTM) has long been one of the most followed funds management businesses on the ASX. Platinum was founded by the legendary ASX investor Kerr Neilson in the 1990s.

Ever since, the company has been a beacon of value investing on the ASX, even after Neilson’s departure in 2018. Now, Platinum is headed by its co-founder and Neilson protege Andrew Clifford.

Clifford recently sat down with Livewire for an interview. It makes for some interesting reading.

Discussing both Platinum’s history, and its prediction for the winning investing themes of the future, Clifford shared three insights.

Firstly, he sees a very bright and potentially lucrative shift towards the widespread adoption of electric vehicles. Platinum identifies the Korean company LG Chem as a major play in this space. Mr Clifford calls the company “one of the world’s leading suppliers of batteries”.

Secondly, Clifford identifies an opportunity in the search for replacements for single-use plastics. Pointing to Finnish forestry company UPM Kymmene Oy, he says he is excited about this company’s plans to turn timber products into bio-plastics.

Biotech shares for the future

But, thirdly, Clifford is looking to the biotech space for potential future gains. He predicts biotech will “kickstart a revolution in healthcare. Not only in the way we define and treat diseases but also in the way we manufacture products”:

The speed at which we’re coming up with potential solutions in the biotech world — whether it’s gene editing or mRNA — there are vast amounts of development in different areas of the sector that I think will transform the healthcare landscape…

The great lesson of the last year was obviously the way that mRNA technology could be used to create vaccines. We had investments in both BioNTech SE (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) well ahead of COVID-19 and certainly stepped those up because we knew there would be an opportunity.

Clifford told Livewire that Dr Bianca Ogden, Platinum’s International Health Care fund manager, frequently points out how “molecular biology and computer science are converging” with Artificial Intelligence (AI).

In the report, Clifford said Odgen “believes that in the next 10 years we will start defining neurological disorders by their molecular profile akin to what we do in oncology”.

Exciting stuff.

The Motley Fool recently looked at some of the ASX’s best-performing biotech shares over the 2021 financial year so make sure to check those out next.

The post This ASX fund manager is predicting big things for biotech shares appeared first on The Motley Fool Australia.

More reading

• These ASX 200 shares are the most tightly held by individual insiders
• Why Alkane, Carsales, Platinum, & Stockland shares are tumbling lower
• Leading brokers name 3 ASX shares to sell today
• ASX 200 midday update: Nearmap rockets, Incitec Pivot jumps
• Why the Platinum (ASX:PTM) share price is sinking 7.5% on Tuesday

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Moderna Inc. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2UrouIN

The Kogan.com Ltd (ASX: KGN) share price is edging higher on Tuesday. At the time of writing, the ecommerce company’s shares are up 0.5% to $11.91.

This means the Kogan share price is up over 6% since this time last week. This compares to a 0.9% decline by the S&P/ASX 200 Index (ASX: XJO) over the same period.

Why is the Kogan share price outperforming?

The catalyst for the rise in the Kogan share price appears to have been recent lockdowns across Australia.

Given that Kogan has been struggling with excess inventory after management failed to anticipate a sharp slowdown in online sales once physical stores reopened, investors appear optimistic that the current lockdowns will boost sales and help reduce its inventory levels.

Fellow ecommerce shares Redbubble Ltd (ASX: RBL) and Temple & Webster Group Ltd (ASX: TPW) have also recorded strong gains over the period. The Redbubble share price is up 12% in a week and the Temple & Webster share price is up 7%.

Is it too late to invest?

Although Kogan shares are outperforming, they are still down by a massive 39% since the start of the year.

This means it may not be too late to invest if analysts at Credit Suisse are to be believed. The broker currently has an outperform rating and $17.93 price target on the company’s shares.

Based on the current Kogan share price, this implies potential upside of 50% over the next 12 months.

Credit Suisse believes the issues Kogan is facing will only be temporary and that investors ought to focus on its positive medium term growth prospects. Particularly given how its active customer base continues to grows.

In addition, Cannacord Genuity is positive on Kogan and has a buy rating and $14.00 price target on its shares. While it has been very disappointed with its performance in the second half, it remains positive on the future.

The post Kogan (ASX:KGN) share price jumps 6% in a week appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• 3 reasons why the Kogan (ASX:KGN) share price could be a buy
• These are the 10 most shorted shares on the ASX
• 2 excellent ASX growth shares that could be buys
• Here’s why the Kogan (ASX:KGN) share price is falling on Friday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Kogan.com ltd and Temple & Webster Group Ltd. The Motley Fool Australia owns shares of and has recommended Kogan.com ltd. The Motley Fool Australia has recommended Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/36KjSAb

Pro Medicus Ltd (ASX: PME) is a top class ASX share. The business has a few different factors that make it quality option. Those reasons might partly explain why investors are willing to pay a high earnings multiple for the Pro Medicus share price.

What does Pro Medicus do?

For readers that haven’t heard of Pro Medicus before, it’s a business that describes itself as a leading healthcare informatics company. It provides a full range of medical imaging software and services to hospitals, imaging centres and health care groups worldwide.

A key selling point of its software is that it’s easily deployable in both public and private cloud environments. It has offices in Melbourne, Berlin and San Diego.

Why Pro Medicus is a top class ASX share

There are a few different factors that support the quality label.

Very profitable

Pro Medicus is proving to be very profitable when it comes to its profit margins.

In its FY21 half-year result it showed that its earnings before interest and tax (EBIT) margin improved materially from 51% to 59%. The company said this resulted from increased revenue combined with significantly decreased operational expenditure.

The 59% number may not be sustainable as Pro Medicus starts paying for travel and conferences again. But, the company thinks that the capacity to do things remotely, both in terms of sales and implementations, will mean there can be a “new normal” where it can do more things off-site than the past without reducing its effectiveness. Pro Medicus believes this will result in savings going forwards.

Pro Medicus believes there is scope for margins to improve on what they have been historically. That means a significant portion of new revenue, more than half, can turn into EBIT.

Leading in multiple growth regions

The ASX share has been winning large, multi-year agreements in both North America and Europe. Pro Medicus has essentially won all of these important contracts that have come up for grabs, which may suggest that the company is building a reputation as a very strong player in its sector.

The US is a huge market for healthcare operators because of both the population size and the amount of spending there.

Pro Medicus’ latest contract win was an eight-year deal with The University of Vermont Health Network worth $14 million. Visage will replace multiple legacy PACS (picture archiving and communication system).

The company said that the deal extended its US academic institution footprint.

Exciting potential products

It continues to think about the future. New and improved products could help grow its offering, market position and profit.

Last month, the ASX business announced it had signed a multi-year research collaboration agreement with Mayo Clinic.

The agreement will serve as the framework for collaboration between the two parties to facilitate the development and commercialisation in the field of AI leveraging the Visage ‘AI Accelerator’ platform. Mayo Clinic has a depth of clinical knowledge and extensive research expertise, according to Pro Medicus.

The company says that it sees AI playing a significant role in healthcare, particularly in its field of imaging IT.

Pro Medicus share price valuation

It’s valued at 116x FY23’s estimated earnings according to Commsec.

The post 3 reasons why Pro Medicus (ASX:PME) is a top class share appeared first on The Motley Fool Australia.

More reading

• These ASX 200 shares are the most tightly held by individual insiders
• Pro Medicus (ASX:PME) share price soars to all-time high
• How did the S&P/ASX All Technologies Index (XTX) perform in FY21?
• The 5 best ASX 200 healthcare shares of financial year 2021
• Are these 2 high-flying ASX shares buys?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/2UYJyGi

The Woodside Petroleum Limited (ASX: WPL) share price is slipping today amid news the price of oil plunged last night.  

On Sunday (Monday AEST), OPEC announced it will be adding more oil supplies to the global market.

As The Motley Fool Australia reported earlier today, the WTI crude oil price flopped 7.6% overnight to reach US$66.34 a barrel, while the Brent crude oil price fell 6.9% to hit US$68.52 a barrel.

Woodside Petroleum’s shares have moved in tangent, tumbling 1.81% to trade for $21.92 at the time of writing.

Let’s take a closer look at how the OPEC decision is affecting the Woodside Petroleum share price today.

Price of oil falls

The Woodside Petroleum share price is tracking downwards today as the price of oil reacts to news supply will be increased.

According to reporting by Bloomberg, OPEC has agreed to increase its output of oil by 40,000 barrels per day every month from August.

Doing so will reverse the current production cuts on the fossil fuel by September 2022. Right now, OPEC is withholding 5.8 million barrels of oil a day.  

Sunday’s surprise announcement from OPEC follows a truce between Saudi Arabia and the United Arab Emirates. The two nations had previously disagreed on appropriate supply levels.

Woodside Petroleum is the largest producer of oil and gas in Australia. The squeeze on oil output had benefited the company by sending the price of oil skyrocketing in recent months.

Its share price has tracked roughly alongside the price of oil’s dramatic falls and climbs throughout the pandemic. Today looks to be no different.

Woodside Petroleum share price snapshot

The Woodside Petroleum share price has had a rough ride lately.

Right now, it is 5% lower than it was at the start of 2021. However, it is currently 9% higher than it was this time last year.

The company has a market capitalisation of around $21 billion, with approximately 963 million shares outstanding.  

The post Why the Woodside Petroleum (ASX:WPL) share price is falling on Tuesday appeared first on The Motley Fool Australia.

More reading

• What happened on the US stock market overnight and how could it impact ASX shares?
• ASX energy shares on watch after oil prices sink 8%
• 5 things to watch on the ASX 200 on Tuesday
• ASX energy shares in focus as OPEC+ strikes deal to lift oil production
• ASX 200 Weekly Wrap: ASX shakes off lockdowns to rise higher

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. 

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3ivxS64

The iCar Asia Ltd (ASX: ICQ) share price is tumbling during Tuesday’s session. This comes after the online car platform owner released an announcement to the market earlier.

At the time of writing, the iCar share price is trading 7.81% lower at 44.25 cents, having hit an intra-day low of 42.5 cents earlier.

Here’s what iCar announced and why investors are jumping out.

iCar share price drops on takeover update

Shares in iCar have taken a tumble after the company provided an update on its takeover offer from Carsome. Prior to this morning’s open, iCar announced it has agreed to provide due diligence access to Carsome.

The company’s board cited the decision in order to progress Carsome’s binding acquisition transaction for iCar shares.

After submitting a conditional, non-binding acquisition proposal last week, Carsome had requested a period to undertake its confirmatory due diligence.

iCar’s board reiterated that the proposal remains subject to a number of conditions, including completion of due diligence by Carsome.

In addition to due diligence granted to Carsome, iCar also updated shareholders on its discussions with Autohome Inc.

Late last year, US company Autohome launched a takeover bid for iCar at 50 cents per share. According to today’s announcement, Autohome has decided to terminate discussions in relation to its acquisition of iCar.

More on iCar’s proposed takeover

iCar owns and operates a network of automotive portals and online marketplaces. The company currently operates in Malaysia, Indonesia and Thailand.

Last week, the iCar share price enjoyed a huge boost after the company received a conditional, non-binding indicative proposal from Carsome.

Carsome, a private business based in Singapore, offered to buy all shares in iCar it doesn’t already own for 55 cents per share cash.

Under the proposal, Carsome will buy 89.4 million iCar shares from digital investment group Catcha Investment Corp. Carsome will then pay Catcha with newly issued Carsome shares.

At 55 cents per share, Carsome has valued iCar at around $243 million.

The proposal saw iCar shares rocket around 41% on the day.

Since the start of the year, shares in iCar have soared by almost 19% including today’s price action.  

The post Here’s why the iCar (ASX:ICQ) share price is tumbling 8% today appeared first on The Motley Fool Australia.

More reading

• Here’s why the iCar Asia (ASX:ICQ) share price is up 41%

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3kCjmw6

Bitcoin (CRYPTO: BTC), and cryptocurrencies by extension, are one of the most controversial asset classes that have ever existed. Those who are bullish on Bitcoin are unabashedly and decisively so.

You’ll frequently hear things like: “One day everyone will be paying with Bitcoin”. Or: “You can’t afford not to have Bitcoin in your portfolio” from this camp.

On the other side of the coin (pardon the pun), there are those who think Bitcoin is a con, a ruse or a scam (not necessarily in that order). You’ll hear this ‘bear camp’ say things like: “Bitcoin is useless”. Or: “It has no intrinsic value”.

Both sides have heavy hitters in their column. Bitcoin’s bulls include famous investors like Robert Kiyosaki, Ray Dalio and (occasionally) Elon Musk. On the other hand, those who have decried Bitcoin and cryptocurrencies include the great Waren Buffett and Charlie Munger.

So who’s right? Unfortunate, this is one of those things that will be proven with hindsight one day. A perspective, unfortunately, not yet available.

But today, we can add one famous fund manager to the doubters’ list.

Magellan’s Hamish Douglass says Bitcoin ‘going to zero’

Hamish Douglass is one of the most famous and successful fund managers in Australia. He’s the chief investment officer of Magellan Financial Group Ltd ( ASX: MFG), the ASX’s largest public asset/fund manager. Mr Douglass’ views on everything from tech to the state of the share market are frequently sought after.

That’s why it’s so fascinating to see him come out so brusquely against Bitcoin.

According to a report in the Australian Financial Review this week, Mr Douglass is firmly in that latter camp. He told the AFR that cryptocurrencies are “one of the greatest mass delusions in modern history”.

He also said that the currencies, including Bitcoin, are destined for an ultimate value of zero:

Cryptocurrencies, I have to say, are one of the greatest irrationalities I’ve seen in a very, very long period of time because of the cult-like following it has behind it and the scale that is behind it…

There are millions and millions of people participating. Some of the people, they’ve never invested before and the only bandwagon they’ve ever got on is the cryptocurrency bandwagon and it’s almost like a religion.

Far from seeing any value in cryptos like Bitcoin, Douglass instead labels them as part of the “areas of reckless speculation” that are currently present in global markets.

He points to the recent share price performances of ‘meme stocks’ like Tesla Inc (NASDAQ: TSLA), GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC) as other examples. He says Bitcoin is no different with “zero intrinsic value” and is tipping a sad end:

I can’t tell you when that will happen by the way. It could happen shortly, it could happen quite some time into the future … I think when we look back in 20 years it will be the case study of the irrationality.

A collapse could spark “contagion”

Even though Mr Douglass (as you might expect) doesn’t hold cryptocurrencies like Bitcoin in any Magellan funds, he is still worried about the broader consequences that may occur if investors see a collapse.

He warned the AFR that we could see “a contagious hit to sentiment” if the risk from cryptocurrencies keeps “ballooning”, foreseeing a “contagion in the event of a collapse [hurting] broader investor confidence and [upending] markets”.

Something to note if you’re an investor in cryptocurrencies.

The post This top ASX fundie reckons Bitcoin is going to zero appeared first on The Motley Fool Australia.

More reading

• Bitcoin is worthless… but maybe priceless?
• Down 7% over the week, will Bitcoin find a floor at US$30,000?
• Aussie startup set to launch first Bitcoin (CRYPTO:BTC) payment card with Visa
• 2 ASX 200 blue chip shares that might be the best to buy
• 75% of Aussies think the Bitcoin (CRYPTO:BTC) bubble will burst

Motley Fool contributor Sebastian Bowen owns shares of Bitcoin and Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Bitcoin and Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3xU21Cu

The Antipa Minerals Ltd (ASX: AZY) share price is surging today, up 6.38% after gaining more than 9% in earlier trading. At the time of writing, Antipa shares are changing hands for 5 cents.

Below, we look at the ASX resource explorer’s latest drill results.

What assay results did Antipa report?

The Antipa Minerals share price is soaring after the company reported promising gold results from the remaining first-batch assays of its 2021 drill campaign. Antipa is exploring on its 100%-owned Minyari Dome Project in Western Australia.

The company has now received full assay results for the 11 reverse circulation drill holes from the campaign. These total 3,282 metres.

It said the results prove there are “significant zones of very high‐grade gold‐copper‐silver‐cobalt mineralisation” outside the existing Minyari deposit boundary.

Antipa also highlighted its discovery of new high‐grade gold‐copper mineralisation at Minyari East. It said this extended the overall width of the Minyari mineralisation envelope to roughly 275 metres.

Commenting on the latest batch of results, Antipa’s managing director Roger Mason said:

These exciting 21MYC0216 results confirm the potential for significant resource growth at the Minyari deposit as well as potential for a stand‐alone development opportunity based on an open pit and underground mining operation that is close to Telfer.

We are in the middle of the most active drilling year in Antipa’s history with nine rigs currently drilling across our four Paterson Province projects and we are delighted with the early success of this year’s program to date.

Looking ahead, the company said it would update the market as new drill samples are batched and dispatched for assay.

Antipa Minerals share price snapshot

Over the past 12 months the Antipa Minerals share price has gained 25%. That is largely in line with the 24% gains by the All Ordinaries Index (ASX: XAO) over that same time.

Year to date Antipa Minerals shares are also up 25%.

The post Why the Antipa Minerals (ASX:AZY) share price is surging today appeared first on The Motley Fool Australia.

More reading

• Why Afterpay, ANZ, JB Hi-Fi, & Zip shares are pushing higher
• Why the BHP (ASX:BHP) share price is down 4% this week
• Up 6%, the Zip (ASX:Z1P) share price is surging. Here’s why
• Why the Grange Resources (ASX:GRR) share price is up 7% today
• Oil Search (ASX:OSH) share price jumps 6% after rejecting takeover bid

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3eCSFUl